|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lintoiu-Ursut B, Tulin A and Constantinoiu
S: Recurrence after hepatic resection in colorectal cancer liver
metastasis-review article. J Med Life. 8:12–14. 2015.PubMed/NCBI
|
|
4
|
Liu S, Zheng R, Zhang M, Zhang S, Sun X
and Chen W: Incidence and mortality of colorectal cancer in China,
2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
|
|
5
|
Moroishi T, Hansen CG and Guan KL: The
emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 15:73–79.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao B, Tumaneng K and Guan KL: The Hippo
pathway in organ size control, tissue regeneration and stem cell
self-renewal. Nat Cell Biol. 13:877–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harvey KF, Zhang X and Thomas DM: The
Hippo pathway and human cancer. Nat Rev Cancer. 13:246–257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wierzbicki PM and Rybarczyk A: The Hippo
pathway in colorectal cancer. Folia Histochem Cytobiol. 53:105–119.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Q, Bauden M, Andersson R, Hu D,
Marko-Varga G, Xu J, Sasor A, Dai H, Pawłowski K, Said Hilmersson
K, et al: YAP1 is an independent prognostic marker in pancreatic
cancer and associated with extracellular matrix remodeling. J
Transl Med. 18:772020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Qiu N, Yin J, Zhang J, Liu H, Guo
W, Liu M, Liu T, Chen D, Luo K, et al: SRGN crosstalks with YAP to
maintain chemoresistance and stemness in breast cancer cells by
modulating HDAC2 expression. Theranostics. 10:4290–4307. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou Y, Wang Y, Zhou W, Chen T, Wu Q,
Chutturghoon VK, Lin B, Geng L, Yang Z, Zhou L and Zheng S: YAP
promotes multi-drug resistance and inhibits autophagy-related cell
death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway.
Cancer Cell Int. 19:1792019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qu Y, Zhang L, Wang J, Chen P, Jia Y, Wang
C, Yang W, Wen Z, Song Q, Tan B and Cheng Y: Yes-associated protein
(YAP) predicts poor prognosis and regulates progression of
esophageal squamous cell cancer through epithelial-mesenchymal
transition. Exp Ther Med. 18:2993–3001. 2019.PubMed/NCBI
|
|
13
|
He C, Mao D, Hua G, Lv X, Chen X,
Angeletti PC, Dong J, Remmenga SW, Rodabaugh KJ, Zhou J, et al: The
Hippo/YAP pathway interacts with EGFR signaling and HPV
oncoproteins to regulate cervical cancer progression. EMBO Mol Med.
7:1426–1449. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei X, Jia Y, Lou H, Ma J, Huang Q, Meng
Y, Sun C, Yang Z, Li X, Xu S, et al: Targeting YAP suppresses
ovarian cancer progression through regulation of the PI3K/Akt/mTOR
pathway. Oncol Rep. 42:2768–2776. 2019.PubMed/NCBI
|
|
15
|
Kang W, Tong JH, Chan AW, Lee TL, Lung RW,
Leung PP, So KK, Wu K, Fan D, Yu J, et al: Yes-associated protein 1
exhibits oncogenic property in gastric cancer and its nuclear
accumulation associates with poor prognosis. Clin Cancer Res.
17:2130–2139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu T, Sun L and Zhu X: Yes-associated
protein enhances proliferation and attenuates sensitivity to
cisplatin in human gastric cancer cells. Biomed Pharmacother.
105:1269–1275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Avruch J, Zhou D and Bardeesy N: YAP
oncogene overexpression supercharges colon cancer proliferation.
Cell Cycle. 11:1090–1096. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang
S, Li G, Wang G, Song J, Li Z, et al: YAP1-induced MALAT1 promotes
epithelial-mesenchymal transition and angiogenesis by sponging
miR-126-5p in colorectal cancer. Oncogene. 38:2627–2644. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen C, Zhu D, Zhang H, Han C, Xue G, Zhu
T, Luo J and Kong L: YAP-dependent ubiquitination and degradation
of β-catenin mediates inhibition of Wnt signalling induced by
Physalin F in colorectal cancer. Cell Death Dis. 9:5912018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ling HH, Kuo CC, Lin BX, Huang YH and Lin
CW: Elevation of YAP promotes the epithelial-mesenchymal transition
and tumor aggressiveness in colorectal cancer. Exp Cell Res.
350:218–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaiser S, Park YK, Franklin JL, Halberg
RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, et
al: Transcriptional recapitulation and subversion of embryonic
colon development by mouse colon tumor models and human colon
cancer. Genome Biol. 8:R1312007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hong Y, Downey T, Eu KW, Koh PK and Cheah
PY: A ‘metastasis-prone’ signature for early-stage mismatch-repair
proficient sporadic colorectal cancer patients and its implications
for possible therapeutics. Clin Exp Metastasis. 27:83–90. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sabates-Bellver J, Van der Flier LG, de
Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA,
Bujnicki JM, Menigatti M, et al: Transcriptome profile of human
colorectal adenomas. Mol Cancer Res. 5:1263–1275. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun L, Lu T, Tian K, Zhou D, Yuan J, Wang
X, Zhu Z, Wan D, Yao Y, Zhu X and He S: Alpha-enolase promotes
gastric cancer cell proliferation and metastasis via regulating AKT
signaling pathway. Eur J Pharmacol. 845:8–15. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tania M, Khan MA and Fu J: Epithelial to
mesenchymal transition inducing transcription factors and
metastatic cancer. Tumour Biol. 35:7335–7342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Xiao ZD, Li X, Aziz KE, Gan B,
Johnson RL and Chen J: AMPK modulates Hippo pathway activity to
regulate energy homeostasis. Nat Cell Biol. 17:490–499. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuo CC, Ling HH, Chiang MC, Chung CH, Lee
WY, Chu CY, Wu YC, Chen CH, Lai YW, Tsai IL, et al: Metastatic
colorectal cancer rewrites metabolic program through a
Glut3-YAP-dependent signaling circuit. Theranostics. 9:2526–2540.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peinado H, Portillo F and Cano A:
Transcriptional regulation of cadherins during development and
carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai W, Xu Y, Mo S, Li Q, Yu J, Wang R, Ma
Y, Ni Y, Xiang W, Han L, et al: GLUT3 induced by AMPK/CREB1 axis is
key for withstanding energy stress and augments the efficacy of
current colorectal cancer therapies. Signal Transduct Target Ther.
5:1772020. View Article : Google Scholar : PubMed/NCBI
|
